| |
Adam Adler , B.A. -
Karyn Angell , Ph.D. -
Steven Artandi , M.D., Ph.D. -
Steven Artandi , M.D., Ph.D. -
Steven Artandi , M.D., Ph.D. -
Speranza Avram , MPA -
Jay Azarow , Ph.D. -
Michael Bax , M.S. -
Rachel Bitton , Ph.D. -
Caroline Bliss-Isberg , Ph.D. -
Caroline Bliss-Isberg , Ph.D. -
Deborah Burkhart , Ph.D. -
Robert Carlson , M.D. -
Howard Chang , M.D, Ph.D. -
Zhen Cheng , Ph.D. -
Karlene Cimprich , Ph.D. -
Karlene Cimprich , Ph.D. -
Stanley Cohen , M.D. -
Kate Collie , Ph.D. -
Matthew Cordova , Ph.D. -
Bradley Ekstrand , M.D., Ph.D. -
David Feldman , M.D. -
James Ford , M.D. -
Margaret Fuller , Ph.D. -
Heinz Furthmayr , M.D. -
Janine Giese-Davis , Ph.D. -
Janine Giese-Davis , Ph.D. -
Steven Hancock , M.D. -
Brian Hargreaves , Ph.D. -
Anne-Renee Hartman , M.D. -
Peter Jackson , Ph.D. -
Stefanie Jeffrey , M.D. -
Stefanie Jeffrey , M.D. -
Stefanie Jeffrey , M.D. -
Stefanie Jeffrey , M.D. -
Cheryl Koopman , Ph.D. -
Cheryl Koopman , Ph.D. -
Cheryl Koopman , Ph.D. -
Cheryl Koopman , Ph.D. -
Cheryl Koopman , Ph.D. -
Mary Anne Kreshka , M.A. -
Mary Anne Kreshka , M.A. -
Allison Kurian , M.D. -
Allison Kurian , M.D. -
Jennifer Lahti , M.S. -
Frances Lau , M.S. -
Craig Levin , Ph.D. -
Ronald Levy , M.D. -
Joseph Lipsick , M.D.,Ph.D. -
Yuefeng Lu , Ph.D. -
Quan Lu , Ph.D. -
Patrick Lupardus , B.S. -
Lisa McPherson , Ph.D. -
Daria Mochly-Rosen , Ph.D. -
Sylvia Plevritis , Ph.D. -
Jonathan Pollack , M.D., Ph.D. -
Jonathan Pollack , M.D., Ph.D. -
Rebecca Rakow-Penner , M.S. -
Stanley Rockson , M.D. -
Glenn Rosen , M.D. -
Yohei Shimono , M.D., Ph.D. -
Tatana Spicakova , Ph.D. -
David Spiegel , M.D. -
David Spiegel , M.D. -
David Spiegel , M.D. -
Devon Thompson , M.Sc., Ph.D. -
Brian Thorndyke , Ph.D. -
Thea Tlsty , Ph.D. -
Irene Wapnir , M.D. -
Wensheng Wei , Ph.D. -
Ronald Weigel , M.D., Ph.D. -
Lynn Westphal , M.D. -
Alice Whittemore , Ph.D., M.A. -
Dieter Wolf , M.D. -
Albert Wong , M.D. -
Joseph Wu , M.D., Ph.D. -
Dawn Yean , Ph.D. -
Hong Zhang , Ph.D. -
|
| Title[sort] |
Cycle |
Award[sort] |
| Enhancing Trastuzumab Therapy with an NK Activating Antibody |
2010 (Cycle 16) |
$225,389 |
| Investigator(s): Ronald Levy , M.D. |
16IB-0095 |
| Electronics for High Resolution Breast-Dedicated PET |
2010 (Cycle 16) |
$76,000 |
| Investigator(s): Frances Lau , M.S. |
16GB-0060 |
| MRI Guided Focused Ultrasound in Breast Cancer Treatment |
2010 (Cycle 16) |
$88,467 |
| Investigator(s): Rachel Bitton , Ph.D. |
16FB-0090 |
| Measuring Real-World Breast Cancer Outcomes |
2010 (Cycle 16) |
$1,066,225 |
| Investigator(s): Allison Kurian , M.D. |
16OB-0149 |
| Discovery of Fusion Genes in Breast Cancer |
2009 (Cycle 15) |
$160,000 |
| Investigator(s): Jonathan Pollack , M.D., Ph.D. |
15IB-0123 |
| Novel Tumor Suppressors in Breast Development and Cancer |
2009 (Cycle 15) |
$231,058 |
| Investigator(s): Margaret Fuller , Ph.D. |
15IB-0068 |
| The Role of EGF Variant mLEEK and Grp78 in Breast Cancer |
2009 (Cycle 15) |
$241,380 |
| Investigator(s): Albert Wong , M.D. |
15IB-0080 |
| Imaging of Novel Stem Cell Therapy Targeting Breast Cancer |
2008 (Cycle 14) |
$239,213 |
| Investigator(s): Joseph Wu , M.D., Ph.D. |
14IB-0039 |
| Novel Small Proteins for PET Imaging of Breast Cancer |
2008 (Cycle 14) |
$261,806 |
| Investigator(s): Zhen Cheng , Ph.D. |
14IB-0091 |
| Functional Breast MRI with BOLD Contrast |
2008 (Cycle 14) |
$76,000 |
| Investigator(s): Rebecca Rakow-Penner , M.S. |
14GB-0004 |
| Multinuclear MRI of Breast Tumors |
2007 (Cycle 13) |
$236,771 |
| Investigator(s): Brian Hargreaves , Ph.D. |
13IB-0074 |
| Exploring the Role of PARP Inhibitors in Breast Cancer |
2007 (Cycle 13) |
$157,516 |
| Investigator(s): Karlene Cimprich , Ph.D. |
13IB-0029 |
| Engineering EGFR Antagonists for Breast Tumor Targeting |
2007 (Cycle 13) |
$75,992 |
| Investigator(s): Jennifer Lahti , M.S. |
13GB-0161 |
| Novel Regulation of the Rb Pathway in Breast Epithelium |
2007 (Cycle 13) |
$74,808 |
| Investigator(s): Deborah Burkhart , Ph.D. |
13GB-0150 |
| Determinants of Response to Microtubule Stabilizing Drugs |
2007 (Cycle 13) |
$66,302 |
| Investigator(s): Tatana Spicakova , Ph.D. |
13FB-0144 |
| Expanding Rural Access: Distance Delivery of Support Groups |
2007 (Cycle 13) |
$290,337 |
| Investigator(s): Cheryl Koopman , Ph.D. |
13BB-2400 |
| Telomerase, Mammary Stem Cells, and Breast Cancer |
2007 (Cycle 13) |
$360,277 |
| Investigator(s): Steven Artandi , M.D., Ph.D. |
13NB-0179 |
| A Targeted Therapy for Wound-like Breast Cancers |
2006 (Cycle 12) |
$232,934 |
| Investigator(s): Howard Chang , M.D, Ph.D. |
12IB-0063 |
| Breast Cancer Metastasis: a Heritable Trait? |
2006 (Cycle 12) |
$264,595 |
| Investigator(s): Alice Whittemore , Ph.D., M.A. |
12IB-0167 |
| Breast Tumor Inhibition by Vitamin D in a Mouse Model |
2006 (Cycle 12) |
$234,388 |
| Investigator(s): David Feldman , M.D. |
12IB-0074 |
| New Technology to Enhance PET Imaging of Breast Cancer |
2006 (Cycle 12) |
$154,879 |
| Investigator(s): Craig Levin , Ph.D. |
12IB-0092 |
| MYC and CSN5 in the Breast Cancer "Wound Signature" Profile |
2006 (Cycle 12) |
$76,000 |
| Investigator(s): Adam Adler , B.A. |
12GB-0008 |
| Real-Time 3D Ultrasound Image-Guidance for Breast Surgery |
2006 (Cycle 12) |
$66,141 |
| Investigator(s): Michael Bax , M.S. |
12GB-0148 |
| Analysis of MicroRNA Expression in Breast Cancer Stem Cells |
2006 (Cycle 12) |
$134,976 |
| Investigator(s): Yohei Shimono , M.D., Ph.D. |
12FB-0053 |
| Role of Telomerase in Mammary Stem Cell Function |
2005 (Cycle 11) |
$236,379 |
| Investigator(s): Steven Artandi , M.D., Ph.D. |
11IB-0174 |
| The Role of B-Myb in Human Breast Cancer Progression |
2005 (Cycle 11) |
$156,106 |
| Investigator(s): Joseph Lipsick , M.D.,Ph.D. |
11IB-0138 |
| Stem Cells of Molecularly Diverse ER-Negative Breast Cancers |
2005 (Cycle 11) |
$234,165 |
| Investigator(s): Stefanie Jeffrey , M.D. |
11IB-0175 |
| Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2 |
2005 (Cycle 11) |
$234,071 |
| Investigator(s): Stanley Rockson , M.D. |
11IB-0172 |
| Cost-effectiveness of Breast MRI Screening by Cancer Risk |
2005 (Cycle 11) |
$49,647 |
| Investigator(s): Allison Kurian , M.D. |
11FB-0051 |
| Removing Respiratory Artifacts in Nuclide Breast Imaging |
2005 (Cycle 11) |
$31,556 |
| Investigator(s): Brian Thorndyke , Ph.D. |
11FB-0170 |
| Expanding Rural Access: Distance Delivery of Support Groups |
2004 (Cycle 10) |
$62,656 |
| Investigator(s): Cheryl Koopman , Ph.D. |
10AB-2801 |
| Characterizing Breast Cancer Cells in Blood and Bone Marrow |
2004 (Cycle 10) |
$155,781 |
| Investigator(s): Robert Carlson , M.D. |
10IB-0073 |
| Profiling Enzyme Activities in Human Breast Cancer |
2004 (Cycle 10) |
$400,000 |
| Investigator(s): Stefanie Jeffrey , M.D. |
10EB-1086 |
| Interactive Technology to Support Rural Women and Families |
2003 (Cycle IX) |
$3,333 |
| Investigator(s): Cheryl Koopman , Ph.D. |
9AB-1400 |
| Interactive Technology to Support Rural Women and Families |
2003 (Cycle IX) |
$3,333 |
| Investigator(s): Mary Anne Kreshka , M.A. |
9AB-1400 |
| Assessing the Impact of Shame and Guilt in Recovery |
2003 (Cycle IX) |
$153,535 |
| Investigator(s): Janine Giese-Davis , Ph.D. |
9IB-0191 |
| 'Art for Recovery': Expanding Access for the Underserved |
2003 (Cycle IX) |
$83,368 |
| Investigator(s): Kate Collie , Ph.D. |
9FB-0115 |
| Genetic Alterations in MRI Screen-Detected Breast Lesions |
2002 (Cycle VIII) |
$145,649 |
| Investigator(s): James Ford , M.D. |
8DB-0153 |
| Genetic Alterations in MRI Screen-Detected Breast Lesions |
2002 (Cycle VIII) |
$145,649 |
| Investigator(s): Sylvia Plevritis , Ph.D. |
8DB-0153 |
| Chemotherapy-Induced Ovarian Damage: Prevention and Impact |
2002 (Cycle VIII) |
$82,027 |
| Investigator(s): Lynn Westphal , M.D. |
8AB-1700 |
| Understanding Telomere Dynamics in the Breast |
2002 (Cycle VIII) |
$681,564 |
| Investigator(s): Steven Artandi , M.D., Ph.D. |
8PB-0155 |
| Identifying Sources of Genomic Instability in Breast Cancer |
2002 (Cycle VIII) |
$119,059 |
| Investigator(s): Karlene Cimprich , Ph.D. |
8IB-0090 |
| Regulation of the Rad1 Checkpoint Complex in Breast Cancer |
2002 (Cycle VIII) |
$59,987 |
| Investigator(s): Patrick Lupardus , B.S. |
8GB-0091 |
| Using Microarrays to Estimate Breast Cancer Risk |
2002 (Cycle VIII) |
$34,233 |
| Investigator(s): Bradley Ekstrand , M.D., Ph.D. |
8FB-0108 |
| Locating Novel Breast Cancer Genes using DNA Microarrays |
2002 (Cycle VIII) |
$477,295 |
| Investigator(s): Jonathan Pollack , M.D., Ph.D. |
8KB-0135 |
| Breast Stromal Genes Act as Early Markers of Malignancy |
2002 (Cycle VIII) |
$398,072 |
| Investigator(s): Stefanie Jeffrey , M.D. |
8EB-1106 |
| Breast Stromal Genes Act as Early Markers of Malignancy |
2002 (Cycle VIII) |
$398,072 |
| Investigator(s): Thea Tlsty , Ph.D. |
8EB-1106 |
| Selective Targeting of Breast Cancer with Radioiodide |
2001 (Cycle VII) |
$315,200 |
| Investigator(s): Irene Wapnir , M.D. |
7WB-0137 |
| The Role of BRCA1 in Nucleotide Excision Repair |
2001 (Cycle VII) |
$85,968 |
| Investigator(s): Anne-Renee Hartman , M.D. |
7FB-0077 |
| Regulation of the ATR Checkpoint Response in Breast Cancer |
2001 (Cycle VII) |
$86,297 |
| Investigator(s): Dawn Yean , Ph.D. |
7FB-0157 |
| Genes That Modulate Dioxin-Induced Breast Cancer |
2001 (Cycle VII) |
$84,731 |
| Investigator(s): Quan Lu , Ph.D. |
7FB-0123 |
| Does a Peer Navigator Improve Quality of Life at Diagnosis? |
2001 (Cycle VII) |
$772,073 |
| Investigator(s): David Spiegel , M.D. |
7BB-2400S |
| Does a Peer Navigator Improve Quality of Life at Diagnosis? |
2001 (Cycle VII) |
$772,073 |
| Investigator(s): Caroline Bliss-Isberg , Ph.D. |
7BB-2400S |
| Does a Peer Navigator Improve Quality of Life at Diagnosis? |
2000 (Cycle VI) |
$159,147 |
| Investigator(s): David Spiegel , M.D. |
6AB-1100 |
| Does a Peer Navigator Improve Quality of Life at Diagnosis? |
2000 (Cycle VI) |
$159,147 |
| Investigator(s): Caroline Bliss-Isberg , Ph.D. |
6AB-1100 |
| Genes Determining Estrogen Susceptibility in Breast Cancer |
2000 (Cycle VI) |
$86,400 |
| Investigator(s): Wensheng Wei , Ph.D. |
6FB-0106 |
| Metastasis Suppressor Genes for Breast Cancer |
2000 (Cycle VI) |
$312,937 |
| Investigator(s): Stanley Cohen , M.D. |
6JB-0008 |
| The Control of Breast Cancer Cell Death |
2000 (Cycle VI) |
$306,149 |
| Investigator(s): Daria Mochly-Rosen , Ph.D. |
6JB-0056 |
| Breast Cancer Screening in Women Surviving Hodgkin's Disease |
1999 (Cycle V) |
$1,033,898 |
| Investigator(s): Steven Hancock , M.D. |
5PB-0165 |
| Cloning of Senescence Genes in Mammary Epithelial Cells |
1999 (Cycle V) |
$75,034 |
| Investigator(s): Hong Zhang , Ph.D. |
5FB-0067 |
| Do Community Cancer Groups Enhance Well-being? |
1999 (Cycle V) |
$74,968 |
| Investigator(s): Matthew Cordova , Ph.D. |
5FB-0036 |
| Generativity and Meaning-making as Resilience Factors in Br |
1999 (Cycle V) |
$0 |
| Investigator(s): Jay Azarow , Ph.D. |
5FB-0168 |
| Characterization of hAG-2 and Its Role in Breast Cancer |
1999 (Cycle V) |
$166,465 |
| Investigator(s): Devon Thompson , M.Sc., Ph.D. |
5KB-0083 |
| A Support Group Alternative for Rural and Isolated Women |
1999 (Cycle V) |
$588,328 |
| Investigator(s): Cheryl Koopman , Ph.D. |
5BB-1801 |
| A Support Group Alternative for Rural and Isolated Women |
1999 (Cycle V) |
$588,328 |
| Investigator(s): Mary Anne Kreshka , M.A. |
5BB-1801 |
| GATA-3 Expression in Hormone Responsive Breast Cancer |
1999 (Cycle V) |
$232,444 |
| Investigator(s): Ronald Weigel , M.D., Ph.D. |
5JB-0047 |
| Role of the POP1 Gene in Breast Cancer Genomic Stability |
1999 (Cycle V) |
$112,710 |
| Investigator(s): Peter Jackson , Ph.D. |
5JB-0121 |
| Breast Cancer Gene Expression Using Amplified Core Biopsies |
1999 (Cycle V) |
$155,286 |
| Investigator(s): Stefanie Jeffrey , M.D. |
5JB-0126 |
| Do Community Cancer Support Groups Reduce Physiologic Stress |
1998 (Cycle IV) |
$726,152 |
| Investigator(s): David Spiegel , M.D. |
4BB-2901 |
| A Novel Drug Induces Apoptosis in Breast Cancer Cells |
1998 (Cycle IV) |
$228,595 |
| Investigator(s): Glenn Rosen , M.D. |
4JB-0057 |
| A Community-based Workbook for Helping Rural Cancer Patients |
1997 (Cycle III) |
$58,512 |
| Investigator(s): Cheryl Koopman , Ph.D. |
3AB-1301 |
| Control of DNA Replication in Breast Cancer |
1997 (Cycle III) |
$47,543 |
| Investigator(s): Dieter Wolf , M.D. |
3FB-0021 |
| Modulation of Drug Resistance by Protein Kinase C Inhibitors |
1997 (Cycle III) |
$24,182 |
| Investigator(s): Yuefeng Lu , Ph.D. |
3FB-0056 |
| Estrogen Receptor Regulation in Breast Cancer |
1995 (Cycle I) |
$75,238 |
| Investigator(s): Lisa McPherson , Ph.D. |
1FB-0377 |
| Does Change in Emotional Expression Mediate Cancer Survival? |
1995 (Cycle I) |
$74,848 |
| Investigator(s): Janine Giese-Davis , Ph.D. |
1FB-0383 |
| Effects of Stress and Support on Delay in Cancer Treatment |
1995 (Cycle I) |
$76,087 |
| Investigator(s): Karyn Angell , Ph.D. |
1FB-0490 |
| Malignant Transformation in Breast Epithelium |
1995 (Cycle I) |
$54,000 |
| Investigator(s): Heinz Furthmayr , M.D. |
1SB-0004 |
